Treating Autoimmune Pancreatitis Without Steroids: Researchers Develop Novel Approach
Autoimmune pancreatitis (AIP) is usually treated with steroids, which may cause severe side effects. Now, researchers from Japan suggest that the selective activation of the transcription factor - aryl hydrocarbon receptor (AhR) - could inhibit the development of AIP with minimal side effects.